MyFinsight
Home
Blog
About
Back
Income Statement
Hemab Therapeutics Holdings, Inc. (COAG)
Hemab Therapeutics Holdings, Inc. (COAG)
source: myfinsight.com
Net loss
-$24,150K
Interest income
$2,858K
Loss before income
tax expense
-$24,053K
Income tax (expense)
benefit
$97K
Total other income,
net
$2,026K
Other (expense)
income, net
-$832K
Loss from operations
-$26,079K
Total operating
expenses
$26,079K
Research and development
$20,336K
General and
administrative
$5,743K
Back